EQL Pharma get Glycopyrronium EQL Pharma approved
EQL Pharma has today received the approval of Glycopyrronium EQL Pharma solution for injection 0.2mg/ml from the Danish Medicines Agency and approvals in Sweden, Norway and Finland are expected shortly.Glycopyrronium EQL Pharma contains glycopyrronium bromide and is a so-called anticholinergic which is used in hospital care, among other things, to counteract salivary secretion during operations in the mouth, throat or trachea. Glycopyrronium EQL Pharma will be EQL's third approved inpatient care product and will be sold through public tenderering in all four Nordic countries. The